| Neal J Peterson, MD | |
|
510 S Cowley St, Spokane, WA 99202-1332 | |
| (509) 838-2531 | |
| Not Available |
| Full Name | Neal J Peterson |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 21 Years |
| Location | 510 S Cowley St, Spokane, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033320817 | NPI | - | NPPES |
| 8484289 | Medicaid | WA | |
| 0222004 | Other | WA | L&I |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | MD00048100 (Washington) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Multicare Health System | 7719899897 | 1704 |
News Archive
Synthetic Biologics, Inc., a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, announced today the formation of a Clinical Advisory Board (CAB) to support development of SYN-004, the Company's lead anti-infective product candidate for the prevention of the devastating effects of Clostridium difficile (C. difficile)
By comparing the DNA of patients with multiple sclerosis whose symptoms are reduced by interferon beta therapy to the DNA of those who continue to experience relapses, researchers may have identified important genetic differences between the two, according to an article posted online that will appear in the March 2008 print issue of Archives of Neurology.
Are you facing an issue that's having an effect on your life? Do you wish you had a secure environment where you could share openly and get real-life solutions you can start applying immediately? Enter FOCUS 7, a new forum in metro Detroit where individuals can meet, participate and learn how to resolve specific issues with the help of an expert on that topic.
The UK population is rapidly getting older: a predicted 1 in 4 people will be over the age of 65 by 2031. Ensuring that an increasingly ageing population stays healthy and mobile is a challenge for both the Government and the scientific research community.
› Verified 8 days ago
| Entity Name | Multicare Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497766638 PECOS PAC ID: 7719899897 Enrollment ID: O20031105000760 |
News Archive
Synthetic Biologics, Inc., a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, announced today the formation of a Clinical Advisory Board (CAB) to support development of SYN-004, the Company's lead anti-infective product candidate for the prevention of the devastating effects of Clostridium difficile (C. difficile)
By comparing the DNA of patients with multiple sclerosis whose symptoms are reduced by interferon beta therapy to the DNA of those who continue to experience relapses, researchers may have identified important genetic differences between the two, according to an article posted online that will appear in the March 2008 print issue of Archives of Neurology.
Are you facing an issue that's having an effect on your life? Do you wish you had a secure environment where you could share openly and get real-life solutions you can start applying immediately? Enter FOCUS 7, a new forum in metro Detroit where individuals can meet, participate and learn how to resolve specific issues with the help of an expert on that topic.
The UK population is rapidly getting older: a predicted 1 in 4 people will be over the age of 65 by 2031. Ensuring that an increasingly ageing population stays healthy and mobile is a challenge for both the Government and the scientific research community.
› Verified 8 days ago
| Entity Name | Rockwood Clinic Ps |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417953787 PECOS PAC ID: 8527976513 Enrollment ID: O20031117000912 |
News Archive
Synthetic Biologics, Inc., a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, announced today the formation of a Clinical Advisory Board (CAB) to support development of SYN-004, the Company's lead anti-infective product candidate for the prevention of the devastating effects of Clostridium difficile (C. difficile)
By comparing the DNA of patients with multiple sclerosis whose symptoms are reduced by interferon beta therapy to the DNA of those who continue to experience relapses, researchers may have identified important genetic differences between the two, according to an article posted online that will appear in the March 2008 print issue of Archives of Neurology.
Are you facing an issue that's having an effect on your life? Do you wish you had a secure environment where you could share openly and get real-life solutions you can start applying immediately? Enter FOCUS 7, a new forum in metro Detroit where individuals can meet, participate and learn how to resolve specific issues with the help of an expert on that topic.
The UK population is rapidly getting older: a predicted 1 in 4 people will be over the age of 65 by 2031. Ensuring that an increasingly ageing population stays healthy and mobile is a challenge for both the Government and the scientific research community.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Neal J Peterson, MD Po Box 3649, Spokane, WA 99220-3649 Ph: () - | Neal J Peterson, MD 510 S Cowley St, Spokane, WA 99202-1332 Ph: (509) 838-2531 |
News Archive
Synthetic Biologics, Inc., a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, announced today the formation of a Clinical Advisory Board (CAB) to support development of SYN-004, the Company's lead anti-infective product candidate for the prevention of the devastating effects of Clostridium difficile (C. difficile)
By comparing the DNA of patients with multiple sclerosis whose symptoms are reduced by interferon beta therapy to the DNA of those who continue to experience relapses, researchers may have identified important genetic differences between the two, according to an article posted online that will appear in the March 2008 print issue of Archives of Neurology.
Are you facing an issue that's having an effect on your life? Do you wish you had a secure environment where you could share openly and get real-life solutions you can start applying immediately? Enter FOCUS 7, a new forum in metro Detroit where individuals can meet, participate and learn how to resolve specific issues with the help of an expert on that topic.
The UK population is rapidly getting older: a predicted 1 in 4 people will be over the age of 65 by 2031. Ensuring that an increasingly ageing population stays healthy and mobile is a challenge for both the Government and the scientific research community.
› Verified 8 days ago
Dr. Jeffery M. Snow, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 427 S Bernard St, Spokane, WA 99204 Phone: 509-456-0107 Fax: 509-747-2635 | |
Robert Samuel Wirthlin, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 427 S Bernard St, Spokane, WA 99204 Phone: 509-456-0107 Fax: 509-747-2635 | |
Mr. Talmage Jay Broadbent, MD,PHD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 626 S. Sheridan St, Spokane, WA 99202 Phone: 509-279-2176 Fax: 509-279-2941 | |
Christian Spencer Draper, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 9911 N Nevada St Ste B, Spokane, WA 99218 Phone: 509-484-5710 Fax: 509-487-1000 | |
Dr. Erik Dale Skoog, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 427 S Bernard St, Spokane, WA 99204 Phone: 509-456-0107 Fax: 509-747-2635 | |
Dr. Barbara A. Smit, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 427 S Bernard St, Spokane, WA 99204 Phone: 509-456-0107 Fax: 509-747-2635 |